Pooled analysis of the safety and tolerability of desvenlafaxine Succinate compared with placebo in the treatment of major depressive disorder

被引:1
|
作者
Clayton, A. H. [1 ]
Kornstein, S. G. [2 ]
Lamm, L. [3 ]
Rosas, G. [3 ]
Tourian, K. A. [3 ]
机构
[1] Univ Virginia, Charlottesville, VA USA
[2] Virginia Commonwealth Univ, Richmond, VA USA
[3] Wyeth Res, Collegeville, PA USA
关键词
D O I
10.1016/j.eurpsy.2008.01.321
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:S201 / S201
页数:1
相关论文
共 50 条
  • [1] An Integrated Analysis of the Safety and Tolerability of Desvenlafaxine Compared with Placebo in the Treatment of Major Depressive Disorder
    Clayton, Anita H.
    Kornstein, Susan G.
    Rosas, Gregory
    Guico-Fabia, Christine
    Tourian, Karen A.
    [J]. CNS SPECTRUMS, 2009, 14 (04) : 183 - 195
  • [2] An integrated analysis of the efficacy of desvenlafaxine succinate compared with placebo in the treatment of major depressive disorder
    Thase, M. E.
    Kornstein, S. G.
    Tummala, R.
    Germain, J. M.
    Jiang, Q.
    Ahmed, S.
    Ninan, P. T.
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 : S208 - S208
  • [3] Efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder
    Kamath, Jayesh
    DeMartinis, Nicholas
    Handratta, Venkatesh
    [J]. FUTURE NEUROLOGY, 2007, 2 (04) : 361 - 371
  • [4] Efficacy of desvenlafaxine compared with placebo in patients with major depressive disorder: A pooled anlaysis
    Thase, M.
    Kornstein, S. G.
    Tummala, R.
    Germain, J. M.
    Jiang, Q.
    Ninan, P. T.
    Guico-Pabia, C.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 200 - 200
  • [5] Desvenlafaxine succinate for the treatment of major depressive disorder
    Lohoff, Falk W.
    Rickels, Karl
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (12) : 2129 - 2136
  • [6] Desvenlafaxine succinate for major depressive disorder
    Sproule, Beth A.
    Hazra, Monica
    Pollock, Bruce G.
    [J]. DRUGS OF TODAY, 2008, 44 (07) : 475 - 487
  • [7] Randomized, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder
    DeMartinis, N.
    Yeung, P. P.
    Entsuah, R.
    Manley, A. L.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S233 - S234
  • [8] Safety and Tolerability of Desvenlafaxine in Children and Adolescents with Major Depressive Disorder
    Findling, Robert L.
    Groark, James
    Chiles, Deborah
    Ramaker, Sara
    Yang, Lingfeng
    Tourian, Karen A.
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2014, 24 (04) : 201 - 209
  • [9] An Integrated Analysis of the Efficacy of Desvenlafaxine Compared with Placebo in Patients with Major Depressive Disorder
    Thase, Michael E.
    Kornstein, Susan G.
    Germain, Jean-Michel
    Jiang, Qin
    Guico-Pabia, Christine
    Ninan, Philip T.
    [J]. CNS SPECTRUMS, 2009, 14 (03) : 144 - 154
  • [10] A pooled analysis of two placebo-controlled trials of desvenlafaxine in major depressive disorder
    Lieberman, Daniel Z.
    Montgomery, Stuart A.
    Tourian, Karen A.
    Brisard, Claudine
    Rosas, Gregory
    Padmanabhan, Krishna
    Germain, Jean-Michel
    Pitrosky, Bruno
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (04) : 188 - 197